Myeloma
📧 Sign up to get email alerts when something new happens for Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For CAR-T Cell Immunotherapy [NA]
A completed clinical trial evaluating exercise prehabilitation in older patients with hematological malignancies preparing for CAR-T cell im…
-
CLINICAL_TRIALS trial_result · 2025-07-29Clinical Trial Update: PROactive Evaluation of Function to Avoid CardioToxicity [Phase 2]
The Phase 2 PROactive trial evaluating strategies to prevent cardiotoxicity in cancer patients was terminated, and results were posted in 20…
-
CLINICAL_TRIALS trial_result · 2019-07-16Clinical Trial Update: Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene [Phase 1, Phase 2]
Phase 1/2 trial evaluating donor lymphocyte infusion of T-cells genetically modified with an iCasp9 suicide gene for leukemia and myeloma; t…
-
CLINICAL_TRIALS trial_result · 2019-04-08Clinical Trial Update: Targeted Radiotherapy in HSCT for Poor Risk Haematological Malignancy [Phase 1, Phase 2]
A phase 1/2 trial evaluating targeted radiotherapy in hematopoietic stem cell transplantation for poor risk hematologic malignancies has com…
-
CLINICAL_TRIALS trial_result · 2014-03-17Clinical Trial Update: Minor Histocompatibility Vaccination After Allogeneic Stem Cell Transplantation for Advanced Hematologic Malignancies [Phase 1]
A Phase 1 study of minor histocompatibility vaccination after allogeneic stem cell transplantation for advanced hematologic malignancies has…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.